Abbott Laboratoriesvs.IDEXX Laboratories
ABT vs IDXX · both in Diagnostics, part of the Medicine, pharma & life science value chain: Tests, imaging and assays that support clinical decision-making.
Abbott Laboratories is about 3.7× larger than IDEXX Laboratories by market cap; Abbott Laboratories trades at the lower P/E (26.1 vs 40.7); year to date, IDEXX Laboratories leads (−16.7% vs −25.0%).
Side by side
| ABT | IDXX | |
|---|---|---|
| Market cap | $164B | $44.5B |
| Price | $93.93 | $563.57 |
| Today | −0.5% | +0.9% |
| Return YTD | −25.0% | −16.7% |
| Return 1Y | −29.7% | +4.2% |
| P/E | 26.1 | 40.7 |
| P/S | 3.6 | 10.0 |
| P/B | 3.1 | 28.6 |
Data as of 2026-07-11 · updates daily after U.S. close
The two companies
Abbott LaboratoriesABT
American healthcare group with four divisions: diagnostics, medical devices (including glucose monitoring), nutrition and generics.
Full ABT profile →IDEXX LaboratoriesIDXX
Diagnostics and software for veterinarians; market leader in veterinary diagnostics.
Full IDXX profile →More comparisons in Diagnostics
See where ABT and IDXX sit in the full Medicine, pharma & life science map — every segment from suppliers to end markets.Open the Life science value chain →